eicosapentaenoic acid ethyl ester has been researched along with ticagrelor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huynh, K | 1 |
1 other study(ies) available for eicosapentaenoic acid ethyl ester and ticagrelor
| Article | Year |
|---|---|
Novel antibody-based reversal agent for ticagrelor.
Topics: Cardiovascular Diseases; Eicosapentaenoic Acid; Humans; Hypertriglyceridemia; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticagrelor | 2019 |